A new study found that continuous glucose monitors can cut healthcare costs by about 20% while also improving outcomes for insulin-dependent diabetes patients, largely by reducing hospitalizations and emergency department visits. Despite these benefits and broad insurance coverage, roughly 80% of eligible patients still are not using the technology — highlighting a significant adoption gap.
The post The CGM Adoption Gap Is Worse Than You Think appeared first on MedCity News.
Fake Claude Code source downloads actually delivered malware – theregister.com
Fake Claude Code source downloads actually delivered malware theregister.com
.webp?w=0&resize=0,0&ssl=1 "How Elite SOCs Cut Escalation Rates by Arming Tier 1 With Better Threat Intelligence")